Shrestha Aruna, Metzler-Zebeli Barbara U, Karembe Hamadi, Sperling Daniel, Koger Simone, Joachim Anja
Department of Pathobiology, Institute of Parasitology, University of Veterinary Medicine Vienna, Vienna, Austria.
Unit Nutritional Physiology, Department of Biomedical Sciences, Institute of Physiology, Pathophysiology and Biophysics, University of Veterinary Medicine Vienna, Vienna, Austria.
Front Microbiol. 2020 May 19;11:983. doi: 10.3389/fmicb.2020.00983. eCollection 2020.
The protozoan parasite causes diarrhea and reduced weight gain in suckling piglets. Infections occur in the first days of life; it is transient but can lead to dysbiosis, exacerbating disease and increasing mortality. Cystoisosporosis is effectively controlled by toltrazuril treatment; however, alterations of the gut microbial composition upon infection and treatment have not been investigated. This study evaluated the development of fecal microbiota of infected piglets in response to treatment with toltrazuril. Thirty-eight conventional piglets were infected with on the first day of life (dol 1). Twenty-six of them received either parenteral or oral toltrazuril 2 days later. Fecal samples were collected pre- and post-weaning (dol 1-15 and 31-38) for microbiota analysis using 16S rRNA amplicon sequencing and during dol 5-18 to determine fecal consistency and parasite excretion. All control animals shed parasites at least once and the majority developed diarrhea, while toltrazuril-treated piglets did not excrete parasites and only had low levels of diarrhea. Age-related shifts in the fecal microbiota composition and increase in diversity and species richness were seen until after weaning. Parasite infection disrupted bacterial maturation 2 weeks after infection. Irrespective of the route of administration, fecal communities of piglets in the treated groups clustered separately and were more diverse compared to that of control piglets during the acute phase of infection on dol 11. Control piglet feces showed higher levels of and , while , , , , and were more abundant in feces of treated piglets on dol 11. Thereafter, treatment-related effects on the microbial communities were small and mainly detectable on dol 34 (5 days post-weaning), potentially indicating that the oral toltrazuril treatment might have had long-term effects on host physiological responses post-weaning. Irrespective of the administration route, toltrazuril prevented -related dysbiosis and maintained species richness and diversity on dol 11. In addition to cystoisosporosis prevention, toltrazuril seems to contribute to the stabilization of the gut microbial development during the suckling phase and thus may reduce the need for antibiotics to control infections with secondary bacterial enteropathogens in infected suckling piglets.
这种原生动物寄生虫会导致哺乳仔猪腹泻并使其体重增加减缓。感染发生在仔猪出生后的头几天;感染是短暂的,但会导致肠道菌群失调,加剧疾病并增加死亡率。托曲珠利治疗可有效控制等孢球虫病;然而,感染和治疗后肠道微生物组成的变化尚未得到研究。本研究评估了感染仔猪在接受托曲珠利治疗后粪便微生物群的发育情况。38头常规饲养的仔猪在出生第一天(第1日龄)感染了[寄生虫名称未给出]。其中26头在2天后接受了托曲珠利的注射或口服治疗。在断奶前后(第1 - 15日龄和第31 - 38日龄)采集粪便样本,使用16S rRNA扩增子测序进行微生物群分析,并在第5 - 18日龄期间测定粪便稠度和寄生虫排泄情况。所有对照动物至少有一次排出寄生虫,且大多数出现腹泻,而接受托曲珠利治疗的仔猪未排出寄生虫,仅有低水平腹泻。在断奶前,粪便微生物群组成随年龄变化,多样性和物种丰富度增加。感染后2周,寄生虫感染扰乱了细菌成熟过程。在第11日龄感染急性期,无论给药途径如何,治疗组仔猪的粪便菌群聚类不同,且与对照仔猪相比更加多样化。对照仔猪粪便中[具体细菌名称未给出]和[具体细菌名称未给出]水平较高,而在第11日龄时,治疗组仔猪粪便中[具体细菌名称未给出]、[具体细菌名称未给出]、[具体细菌名称未给出]、[具体细菌名称未给出]和[具体细菌名称未给出]更为丰富。此后,治疗对微生物群落的影响较小,主要在第34日龄(断奶后5天)可检测到,这可能表明口服托曲珠利治疗可能对断奶后宿主生理反应有长期影响。无论给药途径如何,托曲珠利在第11日龄时预防了[相关细菌名称未给出]相关的菌群失调,并维持了物种丰富度和多样性。除预防等孢球虫病外,托曲珠利似乎有助于哺乳期肠道微生物发育的稳定,因此可能减少感染的哺乳仔猪控制继发性细菌性肠道病原体感染对抗生素的需求。